Trosunilimab

DRUG2 trials

Sponsors

AbbVie

Conditions

Crohn's DiseaseUlcerative Colitis

Phase 2

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

RecruitingNCT06548542

AbbVieCrohn's Disease

Start: 2024-09-04End: 2030-01-01Target: 540Updated: 2026-06-26

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Not yet recruitingNCT07697456

AbbVieCrohn's Disease, Ulcerative Colitis

Start: 2026-07-24End: 2031-10-01Target: 2000Updated: 2026-07-13